Showing 2,861 - 2,880 results of 24,706 for search 'institution program', query time: 0.26s Refine Results
  1. 2861

    In vitro activity of omadacycline against bacterial isolates from bone/joint infections and rare pathogens in the SENTRY antimicrobial surveillance program (2015–2023) by Michael D. Huband, Paul R. Rhomberg, Kelley A. Fedler, Christopher Blankers, Diane Anastasiou, Alisa W. Serio, Mariana Castanheira

    Published 2025-06-01
    “…Omadacycline in vitro activity was assessed against 919 bacterial isolates collected from patients with bone/joint infections in the United States and Europe (2015–2023) and 3945 rarely encountered bacterial pathogens from patients (multiple infection sites) in the United States (2015–2023) as part of the SENTRY Antimicrobial Surveillance Program. program. Methods: Broth microdilution susceptibility testing followed Clinical and Laboratory Standards Institute M07 (2024) and M100 (2024) guidelines. …”
    Get full text
    Article
  2. 2862
  3. 2863
  4. 2864
  5. 2865
  6. 2866
  7. 2867
  8. 2868
  9. 2869
  10. 2870
  11. 2871
  12. 2872
  13. 2873
  14. 2874
  15. 2875
  16. 2876
  17. 2877
  18. 2878
  19. 2879
  20. 2880